376 related articles for article (PubMed ID: 27606344)
1. Neurofilament light chain: a biomarker for genetic frontotemporal dementia.
Meeter LH; Dopper EG; Jiskoot LC; Sanchez-Valle R; Graff C; Benussi L; Ghidoni R; Pijnenburg YA; Borroni B; Galimberti D; Laforce RJ; Masellis M; Vandenberghe R; Ber IL; Otto M; van Minkelen R; Papma JM; Rombouts SA; Balasa M; Öijerstedt L; Jelic V; Dick KM; Cash DM; Harding SR; Jorge Cardoso M; Ourselin S; Rossor MN; Padovani A; Scarpini E; Fenoglio C; Tartaglia MC; Lamari F; Barro C; Kuhle J; Rohrer JD; Teunissen CE; van Swieten JC
Ann Clin Transl Neurol; 2016 Aug; 3(8):623-36. PubMed ID: 27606344
[TBL] [Abstract][Full Text] [Related]
2. Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study.
van der Ende EL; Meeter LH; Poos JM; Panman JL; Jiskoot LC; Dopper EGP; Papma JM; de Jong FJ; Verberk IMW; Teunissen C; Rizopoulos D; Heller C; Convery RS; Moore KM; Bocchetta M; Neason M; Cash DM; Borroni B; Galimberti D; Sanchez-Valle R; Laforce R; Moreno F; Synofzik M; Graff C; Masellis M; Carmela Tartaglia M; Rowe JB; Vandenberghe R; Finger E; Tagliavini F; de Mendonça A; Santana I; Butler C; Ducharme S; Gerhard A; Danek A; Levin J; Otto M; Frisoni GB; Cappa S; Pijnenburg YAL; Rohrer JD; van Swieten JC;
Lancet Neurol; 2019 Dec; 18(12):1103-1111. PubMed ID: 31701893
[TBL] [Abstract][Full Text] [Related]
3. Clinical Value of Longitudinal Serum Neurofilament Light Chain in Prodromal Genetic Frontotemporal Dementia.
Giannini LAA; Seelaar H; van der Ende EL; Poos JM; Jiskoot LC; Dopper EGP; Pijnenburg YAL; Willemse EAJ; Vermunt L; Teunissen CE; van Swieten JC; Meeter LH
Neurology; 2023 Sep; 101(10):e1069-e1082. PubMed ID: 37491327
[TBL] [Abstract][Full Text] [Related]
4. Stratifying the Presymptomatic Phase of Genetic Frontotemporal Dementia by Serum NfL and pNfH: A Longitudinal Multicentre Study.
Wilke C; Reich S; van Swieten JC; Borroni B; Sanchez-Valle R; Moreno F; Laforce R; Graff C; Galimberti D; Rowe JB; Masellis M; Tartaglia MC; Finger E; Vandenberghe R; de Mendonça A; Tagliavini F; Santana I; Ducharme S; Butler CR; Gerhard A; Levin J; Danek A; Otto M; Frisoni G; Ghidoni R; Sorbi S; Bocchetta M; Todd E; Kuhle J; Barro C; ; Rohrer JD; Synofzik M
Ann Neurol; 2022 Jan; 91(1):33-47. PubMed ID: 34743360
[TBL] [Abstract][Full Text] [Related]
5. Serum neurofilament light chain as a surrogate of cognitive decline in sporadic and familial frontotemporal dementia.
Silva-Spínola A; Lima M; Leitão MJ; Durães J; Tábuas-Pereira M; Almeida MR; Santana I; Baldeiras I
Eur J Neurol; 2022 Jan; 29(1):36-46. PubMed ID: 34375485
[TBL] [Abstract][Full Text] [Related]
6. Alterations in Lysosomal, Glial and Neurodegenerative Biomarkers in Patients with Sporadic and Genetic Forms of Frontotemporal Dementia.
Hsiao-Nakamoto J; Chiu CL; VandeVrede L; Ravi R; Vandenberg B; De Groot J; Tsogtbaatar B; Fang M; Auger P; Gould NS; Marchioni F; Powers CA; Davis SS; Suh JH; Alkabsh J; Heuer HW; Lago AL; Scearce-Levie K; Seeley WW; Boeve BF; Rosen HJ; Berger A; Tsai R; Di Paolo G; Boxer AL; Bhalla A; Huang F;
bioRxiv; 2024 Feb; ():. PubMed ID: 38405775
[TBL] [Abstract][Full Text] [Related]
7. Elevated CSF and plasma complement proteins in genetic frontotemporal dementia: results from the GENFI study.
van der Ende EL; Heller C; Sogorb-Esteve A; Swift IJ; McFall D; Peakman G; Bouzigues A; Poos JM; Jiskoot LC; Panman JL; Papma JM; Meeter LH; Dopper EGP; Bocchetta M; Todd E; Cash D; Graff C; Synofzik M; Moreno F; Finger E; Sanchez-Valle R; Vandenberghe R; Laforce R; Masellis M; Tartaglia MC; Rowe JB; Butler C; Ducharme S; Gerhard A; Danek A; Levin J; Pijnenburg YAL; Otto M; Borroni B; Tagliavini F; de Mendonça A; Santana I; Galimberti D; Sorbi S; Zetterberg H; Huang E; van Swieten JC; Rohrer JD; Seelaar H;
J Neuroinflammation; 2022 Sep; 19(1):217. PubMed ID: 36064709
[TBL] [Abstract][Full Text] [Related]
8. Serum Neurofilament Light in Patients with Frontotemporal Dementia Caused by CHMP2B Mutation.
Toft A; Roos P; Jääskeläinen O; Musaeus CS; Henriksen EE; Johannsen P; Nielsen TT; Herukka SK; Hviid Simonsen A; Nielsen JE
Dement Geriatr Cogn Disord; 2020; 49(6):533-538. PubMed ID: 33626531
[TBL] [Abstract][Full Text] [Related]
9. Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia.
Rohrer JD; Woollacott IO; Dick KM; Brotherhood E; Gordon E; Fellows A; Toombs J; Druyeh R; Cardoso MJ; Ourselin S; Nicholas JM; Norgren N; Mead S; Andreasson U; Blennow K; Schott JM; Fox NC; Warren JD; Zetterberg H
Neurology; 2016 Sep; 87(13):1329-36. PubMed ID: 27581216
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid neurofilament concentration reflects disease severity in frontotemporal degeneration.
Scherling CS; Hall T; Berisha F; Klepac K; Karydas A; Coppola G; Kramer JH; Rabinovici G; Ahlijanian M; Miller BL; Seeley W; Grinberg LT; Rosen H; Meredith J; Boxer AL
Ann Neurol; 2014 Jan; 75(1):116-26. PubMed ID: 24242746
[TBL] [Abstract][Full Text] [Related]
11. Neuronal pentraxin 2: a synapse-derived CSF biomarker in genetic frontotemporal dementia.
van der Ende EL; Xiao M; Xu D; Poos JM; Panman JL; Jiskoot LC; Meeter LH; Dopper EG; Papma JM; Heller C; Convery R; Moore K; Bocchetta M; Neason M; Peakman G; Cash DM; Teunissen CE; Graff C; Synofzik M; Moreno F; Finger E; Sánchez-Valle R; Vandenberghe R; Laforce R; Masellis M; Tartaglia MC; Rowe JB; Butler CR; Ducharme S; Gerhard A; Danek A; Levin J; Pijnenburg YA; Otto M; Borroni B; Tagliavini F; de Mendonca A; Santana I; Galimberti D; Seelaar H; Rohrer JD; Worley PF; van Swieten JC;
J Neurol Neurosurg Psychiatry; 2020 Jun; 91(6):612-621. PubMed ID: 32273328
[TBL] [Abstract][Full Text] [Related]
12. CSF neurofilament light concentration is increased in presymptomatic
Rostgaard N; Roos P; Portelius E; Blennow K; Zetterberg H; Simonsen AH; Nielsen JE
Neurology; 2018 Jan; 90(2):e157-e163. PubMed ID: 29237796
[TBL] [Abstract][Full Text] [Related]
13. Neurofilament Light Chain as Biomarker for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.
Verde F; Otto M; Silani V
Front Neurosci; 2021; 15():679199. PubMed ID: 34234641
[TBL] [Abstract][Full Text] [Related]
14. Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia.
Heller C; Foiani MS; Moore K; Convery R; Bocchetta M; Neason M; Cash DM; Thomas D; Greaves CV; Woollacott IO; Shafei R; Van Swieten JC; Moreno F; Sanchez-Valle R; Borroni B; Laforce R; Masellis M; Tartaglia MC; Graff C; Galimberti D; Rowe JB; Finger E; Synofzik M; Vandenberghe R; de Mendonca A; Tagliavini F; Santana I; Ducharme S; Butler CR; Gerhard A; Levin J; Danek A; Frisoni G; Sorbi S; Otto M; Heslegrave AJ; Zetterberg H; Rohrer JD;
J Neurol Neurosurg Psychiatry; 2020 Mar; 91(3):263-270. PubMed ID: 31937580
[TBL] [Abstract][Full Text] [Related]
15. A data-driven disease progression model of fluid biomarkers in genetic frontotemporal dementia.
van der Ende EL; Bron EE; Poos JM; Jiskoot LC; Panman JL; Papma JM; Meeter LH; Dopper EGP; Wilke C; Synofzik M; Heller C; Swift IJ; Sogorb-Esteve A; Bouzigues A; Borroni B; Sanchez-Valle R; Moreno F; Graff C; Laforce R; Galimberti D; Masellis M; Tartaglia MC; Finger E; Vandenberghe R; Rowe JB; de Mendonça A; Tagliavini F; Santana I; Ducharme S; Butler CR; Gerhard A; Levin J; Danek A; Otto M; Pijnenburg YAL; Sorbi S; Zetterberg H; Niessen WJ; Rohrer JD; Klein S; van Swieten JC; Venkatraghavan V; Seelaar H;
Brain; 2022 Jun; 145(5):1805-1817. PubMed ID: 34633446
[TBL] [Abstract][Full Text] [Related]
16. Poly(GP), neurofilament and grey matter deficits in
Meeter LHH; Gendron TF; Sias AC; Jiskoot LC; Russo SP; Donker Kaat L; Papma JM; Panman JL; van der Ende EL; Dopper EG; Franzen S; Graff C; Boxer AL; Rosen HJ; Sanchez-Valle R; Galimberti D; Pijnenburg YAL; Benussi L; Ghidoni R; Borroni B; Laforce R; Del Campo M; Teunissen CE; van Minkelen R; Rojas JC; Coppola G; Geschwind DH; Rademakers R; Karydas AM; Öijerstedt L; Scarpini E; Binetti G; Padovani A; Cash DM; Dick KM; Bocchetta M; Miller BL; Rohrer JD; Petrucelli L; van Swieten JC; Lee SE
Ann Clin Transl Neurol; 2018 May; 5(5):583-597. PubMed ID: 29761121
[TBL] [Abstract][Full Text] [Related]
17. Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders.
Olsson B; Portelius E; Cullen NC; Sandelius Å; Zetterberg H; Andreasson U; Höglund K; Irwin DJ; Grossman M; Weintraub D; Chen-Plotkin A; Wolk D; McCluskey L; Elman L; Shaw LM; Toledo JB; McBride J; Hernandez-Con P; Lee VM; Trojanowski JQ; Blennow K
JAMA Neurol; 2019 Mar; 76(3):318-325. PubMed ID: 30508027
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal Fluid Biomarkers in Patients with Frontotemporal Dementia Spectrum: A Single-Center Study.
Abu-Rumeileh S; Mometto N; Bartoletti-Stella A; Polischi B; Oppi F; Poda R; Stanzani-Maserati M; Cortelli P; Liguori R; Capellari S; Parchi P
J Alzheimers Dis; 2018; 66(2):551-563. PubMed ID: 30320576
[TBL] [Abstract][Full Text] [Related]
19. An update on genetic frontotemporal dementia.
Greaves CV; Rohrer JD
J Neurol; 2019 Aug; 266(8):2075-2086. PubMed ID: 31119452
[TBL] [Abstract][Full Text] [Related]
20. Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD.
Sjögren M; Rosengren L; Minthon L; Davidsson P; Blennow K; Wallin A
Neurology; 2000 May; 54(10):1960-4. PubMed ID: 10822437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
